{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 52.4,
  "market_cap": 232838332416,
  "revenue_ttm": 49795361312.71694,
  "net_income_ttm": 16373146102.871569,
  "ocf_ttm": 19530451246.449986,
  "capex_ttm": 9913852950.457558,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1400915115.1782897,
  "total_debt": 15969390975.071001,
  "cash_and_equivalents": 5140896181.760808,
  "book_value_ttm": 26805932470.81098,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4544451,
  "dividend_yield": 330.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-29T01:40:29Z"
}